论文部分内容阅读
探讨晚期卵巢癌的介入治疗方法及疗效。方法 :对 13例晚期卵巢癌在 DSA下行表阿霉素和顺铂介入治疗并观察疗效、手术切除率及毒副反应。结果 :近期有效率 84.6 % ,对腹水的客观有效率为10 0 .0 % ,手术切除率 80 .0 %。随访 :经 7～ 2 5个月 (平均 16 .5月 )随访 ,13例中 6例无癌存在 ,5例仍在治疗中 ,2例死亡。结论 :表阿霉素 (EPI)、顺铂 (DDP)介入治疗卵巢癌效果显著 ,但术后应辅以 6～ 10个疗程静脉化疗。
To explore the interventional treatment of advanced ovarian cancer and its efficacy. Methods: Thirteen cases of advanced ovarian cancer were treated with epirubicin and cisplatin in DSA. The curative effect, resection rate and toxicity were observed. Results: The recent effective rate was 84.6%. The objective effective rate of ascites was 100.0%. The surgical resection rate was 80.0%. Follow-up: After 7 to 25 months (mean 16.5 months) follow-up, 6 of 13 patients were non-cancerous, 5 were still under treatment and 2 died. Conclusion: Epirubicin (EPI) and cisplatin (DDP) are effective in interventional therapy of ovarian cancer, but 6 ~ 10 courses of intravenous chemotherapy should be supplemented after operation.